PhaseV, a leader in AI/ML-driven clinical development, today announced that the second episode in its webinar series will focus on improving patient-centricity and efficiency in clinical trial design.

The in-licensed antibody represents what iBio believes to be the first functional inhibitor of Activin E, a challenging, yet genetically validated therapeutic target playing a key role in regulating ...

The latest iteration of the ballet flat is...the ballet sneaker. The comfortable shoe has been worn by everyone from Bella ...

Joey Jordison ’s family have shared the drummer’s original design of the Slipknot logo.

Explore how nanosensors are transforming cancer diagnostics by enabling earlier, more accurate, and less invasive detection ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

American Vanguard Corp. $4.21 0.41 10.79% ...